Literature DB >> 16059725

Intravenous exposure to di(2-ethylhexyl)phthalate (DEHP): metabolites of DEHP in urine after a voluntary platelet donation.

Holger M Koch1, Hermann M Bolt, Ralf Preuss, Reinhold Eckstein, Volker Weisbach, Jürgen Angerer.   

Abstract

In this study we investigated human metabolism and excretion of DEHP after intravenous exposure. For this purpose we determined the five major DEHP metabolites in urine samples of a volunteer before and after a platelet donation (dual-needle technique). Plateletpheresis procedures are known to cause a significant DEHP exposure. We observed a sharp increase in urinary DEHP metabolite concentrations after the procedure. Maximum concentrations of 5OH-MEHP, 5oxo-MEHP, 5cx-MEPP and MEHP observed 4 h after the procedure were 822, 729, 577 and 388 microg/l respectively. 2cx-MMHP was excreted at highest concentrations after 8 h (201 microg/l). Due to longer elimination half-times, 5cx-MEPP and 2cx-MMHP were the major metabolites excreted in urine 24 h after the exposure. The 24-h-cumulative excretion of 363 microg 5cx-MEPP, 353 microg 5OH-MEHP, 309 microg 5oxo-MEHP, 178 microg MEHP and 133 microg 2cx-MMHP indicates an absolute exposure of our volunteer of about 2.6 mg DEHP. Related to the body weight this equals a dose of 31.6 microg/kg body weight/day. This indicates that current risk or preventive limit values for DEHP such as the RfD of the US EPA (20 microg/kg/day) and the TDI of the European Union (20-48 microg/kg/day) can be exceeded on the day of the plateletpheresis. The amount of the dose excreted in urine, distribution of the metabolites in urine and all other elimination characteristics after intravenous DEHP exposure are comparable to oral exposure. There are no indications that toxicokinetic behaviour and the toxicity of DEHP are fundamentally different after the two routes of exposure. Therefore, toxicological endpoints observed for DEHP after oral application should also be considered relevant for medical procedures causing intravenous DEHP exposure, like apheresis procedures. Especially women in their reproductive age need to be protected from DEHP exposures exceeding the above mentioned preventive limit values.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16059725     DOI: 10.1007/s00204-005-0004-x

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  12 in total

1.  Extracorporeal tubing in the roller pump raceway: physical changes and particulate generation.

Authors:  Allison J Bednarski Spiwak; Alexander Horbal; Robert Leatherbury; Derek J Hansford
Journal:  J Extra Corpor Technol       Date:  2008-09

2.  Urinary phthalate and phthalate alternative metabolites and isoprostane among couples undergoing fertility treatment.

Authors:  Haotian Wu; Alexandra Olmsted; David E Cantonwine; Shahin Shahsavari; Tayyab Rahil; Cynthia Sites; J Richard Pilsner
Journal:  Environ Res       Date:  2016-11-19       Impact factor: 6.498

Review 3.  Phthalate exposure and children's health.

Authors:  Joseph M Braun; Sheela Sathyanarayana; Russ Hauser
Journal:  Curr Opin Pediatr       Date:  2013-04       Impact factor: 2.856

4.  Oxidative metabolites of diisononyl phthalate as biomarkers for human exposure assessment.

Authors:  Manori J Silva; John A Reidy; James L Preau; Larry L Needham; Antonia M Calafat
Journal:  Environ Health Perspect       Date:  2006-08       Impact factor: 9.031

Review 5.  Integrating biomonitoring exposure data into the risk assessment process: phthalates [diethyl phthalate and di(2-ethylhexyl) phthalate] as a case study.

Authors:  Antonia M Calafat; Richard H McKee
Journal:  Environ Health Perspect       Date:  2006-11       Impact factor: 9.031

Review 6.  Mechanisms mediating environmental chemical-induced endocrine disruption in the adrenal gland.

Authors:  Daniel B Martinez-Arguelles; Vassilios Papadopoulos
Journal:  Front Endocrinol (Lausanne)       Date:  2015-03-04       Impact factor: 5.555

7.  Lycium Barbarum Polysaccharides and Wolfberry Juice Prevent DEHP-Induced Hepatotoxicity via PXR-Regulated Detoxification Pathway.

Authors:  Huan Liu; Xiong Zhou; Shaowen Huang; Jie Yang; Ruijing Liu; Chunhong Liu
Journal:  Molecules       Date:  2021-02-06       Impact factor: 4.411

8.  Evaluation of the Di(2-ethylhexyl)phthalate released from polyvinyl chloride medical devices that contact blood.

Authors:  Hongyu Luo; Guangyu Sun; Yanping Shi; Yong Shen; Kai Xu
Journal:  Springerplus       Date:  2014-01-29

9.  DEHP deregulates adipokine levels and impairs fatty acid storage in human SGBS-adipocytes.

Authors:  Kristina Schaedlich; Scarlett Gebauer; Luise Hunger; Laura-Sophie Beier; Holger M Koch; Martin Wabitsch; Bernd Fischer; Jana Ernst
Journal:  Sci Rep       Date:  2018-02-22       Impact factor: 4.379

10.  Accumulation, morpho-physiological and oxidative stress induction by single and binary treatments of fluoride and low molecular weight phthalates in Spirodela polyrhiza L. Schleiden.

Authors:  Ritika Sharma; Arpna Kumari; Sneh Rajput; Saroj Arora; Rajkumar Rampal; Rajinder Kaur
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.